Over $266,000 in grants were awarded this spring to five research projects. The grants were made for a one to two year period for up to $40,000 a year. These projects represent NTSAD's commitment to fund research that will lead to treatments for rare genetic diseases such as Tay-Sachs, Canavan, GM1 and Sandhoff diseases.
Grants were made for the following proposals:
Development and Validation of a Rapid MS/MS-based Method to Detect HexA deficiency in Tay-Sachs disease
Principal Investigator: Denis Lehotay, PhD
University of Saskatchewan College of Medicine
Intravascular Gene Therapy for Feline GM2
Principal Investigator: Douglas Martin, PhD
Auburn University
Generation of a Knock-in Mutant Hexb Mouse Model
Principal Investigator: Eric Sjoberg
OrPhi Therapeutics
Late Onset Registry and Repository
Principal Investigator: Florian Eichler, MD
Massachusetts General Hospital
Defining Natural History of Canavan Disease through the Development of an International Registry
Co-funded with The Canavan Foundation
Principal Investigator: Heather Lau, MD, MS
Co-Investigator: Paola Leone, PhD
New York University
|